Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Losa

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
Journal of Endocrinological Investigation|March 4, 2025
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter studyMario Detomas, Barbara Altieri, Isabella Nasi-Kordhishti, et al.
Metabolism: Clinical and Experimental|November 18, 2008
Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiencyEmanuela Setola, Lucilla D Monti, Roberto Lanzi, et al.
Endocrine|April 28, 2017
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cellsAurora Aiello, Maria Francesca Cassarino, Simona Nanni, et al.
Translational Oncology|December 2, 2008
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?Francesca Miselli, Tiziana Negri, Alessandro Gronchi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2008
Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked casesMara Colombo, Monica Giarola, Luigi Mariani, et al.
Frontiers in Endocrinology|October 24, 2022
Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndromeMario Detomas, Katrin Ritzel, Isabella Nasi-Kordhishti, et al.
Endocrinology|October 1, 2005
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory actionDamiana Giacomini, Marcelo Páez-Pereda, Marily Theodoropoulou, et al.
Clinical Endocrinology|May 8, 2010
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotypeLaura Montefusco, Marcello Filopanti, Cristina L Ronchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patientsDelia Mezzanzanica, Marina Fabbi, Marina Bagnoli, et al.
Journal of Neuro-Oncology|November 29, 2015
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomasMarco Losa, Fausto Bogazzi, Salvo Cannavo, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Journal of Endocrinological Investigation|March 4, 2025
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter studyMario Detomas, Barbara Altieri, Isabella Nasi-Kordhishti, et al.
Metabolism: Clinical and Experimental|November 18, 2008
Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiencyEmanuela Setola, Lucilla D Monti, Roberto Lanzi, et al.
Endocrine|April 28, 2017
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cellsAurora Aiello, Maria Francesca Cassarino, Simona Nanni, et al.
Translational Oncology|December 2, 2008
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?Francesca Miselli, Tiziana Negri, Alessandro Gronchi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2008
Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked casesMara Colombo, Monica Giarola, Luigi Mariani, et al.
Frontiers in Endocrinology|October 24, 2022
Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndromeMario Detomas, Katrin Ritzel, Isabella Nasi-Kordhishti, et al.
Endocrinology|October 1, 2005
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory actionDamiana Giacomini, Marcelo Páez-Pereda, Marily Theodoropoulou, et al.
Clinical Endocrinology|May 8, 2010
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotypeLaura Montefusco, Marcello Filopanti, Cristina L Ronchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patientsDelia Mezzanzanica, Marina Fabbi, Marina Bagnoli, et al.
Journal of Neuro-Oncology|November 29, 2015
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomasMarco Losa, Fausto Bogazzi, Salvo Cannavo, et al.
Pageof 17